ID   SCCOHT-CH-1
AC   CVCL_D1GG
DR   Wikidata; Q127384193
RX   PubMed=37535222;
CC   Population: Chinese.
CC   Characteristics: Has extremely strong migratory and invasive abilities (PubMed=37535222).
CC   Doubling time: 33.02 hours (PubMed=37535222).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; c.939_940insT; Zygosity=Heterozygous (PubMed=37535222).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Tyr877Tyr (c.2631C>A); ClinVar=VCV000537876; Zygosity=Heterozygous (PubMed=37535222).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=37535222
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 9,13
ST   D18S51: 13,16
ST   D19S433: 11,14.2
ST   D21S11: 30,32.2
ST   D2S1338: 19,24
ST   D3S1358: 14,15
ST   D5S818: 7,10
ST   D7S820: 9,10
ST   D8S1179: 16
ST   FGA: 24,26
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C40439; Ovarian small cell carcinoma, hypercalcemic type
DI   ORDO; Orphanet_370396; Small cell carcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
RX   PubMed=37535222; DOI=10.1007/s13577-023-00966-8; PMCID=PMC10587334;
RA   Gao Y., Zheng K.-W., Kang M.-Y., Xu J., Ning Y., Hu W.-G., Li K., Kang Y.,
RA   Xu C.-J.;
RT   "Establishment and characterization of a novel cell line (SCCOHT-CH-1)
RT   and PDX models derived from Chinese patients of small cell ovarian
RT   carcinoma of the hypercalcemic type.";
RL   Hum. Cell 36:2214-2227(2023).
//